...

Protocol EAY191 Molecular Analysis for Combination Therapy Choice (ComboMATCH)

This ComboMATCH patient screening trial. The study will identify patients with certain gene changes or mutations for treatment using a combination of targeted therapy.


Why this Research Matters

Patients that have a gene change or mutation that matches a certain treatment trial will be asked to be part of that treatment trial. This is a registration study.


Who can Participate

Adult

Detailed eligibility criteria is available on ClinicalTrials.gov. These requirements will be discussed with your doctor and/or study representative. Visit ClinicalTrials.gov to learn more about this study.


Study ID

Protocol Number: 23-1254
More information available at ClinicalTrials.gov: NCT05564377

Meet the Team

Image of Principal Investigator

Robert Lentz, MD

Principal Investigator


Categories

Locations